19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A Randomized Controlled Trial Examining the Efficacy of Motivational Counseling with Observed Therapy for Antiretroviral Therapy Adherence

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study determined whether motivational interviewing-based cognitive behavioral therapy (MI-CBT) adherence counseling combined with modified directly observed therapy (MI-CBT/mDOT) is more effective than MI-CBT counseling alone or standard care (SC) in increasing adherence over time. A three-armed randomized controlled 48-week trial with continuous electronic drug monitored adherence was conducted by randomly assigning 204 HIV-positive participants to either 10 sessions of MI-CBT counseling with mDOT for 24 weeks, 10 sessions of MI-CBT counseling alone, or SC. Poisson mixed effects regression models revealed significant interaction effects of intervention over time on non-adherence defined as percent of doses not-taken (IRR = 1.011, CI = 1.000–1.018) and percent of doses not-taken on time (IRR = 1.006, CI = 1.001–1.011) in the 30 days preceding each assessment. There were no significant differences between groups, but trends were observed for the MI-CBT/mDOT group to have greater 12 week on-time and worse 48 week adherence than the SC group. Findings of modest to null impact on adherence despite intensive interventions highlights the need for more effective interventions to maintain high adherence over time.

          Resumen

          Esta investigación determina si la Terapia Cognitivo-Conductal basada en la Entrevista Motivacional (MI-CBT) combinada con Terapia de Observación Directa modificada (MI-CBT/mDOT) es más efectiva que una intervención que solo incluye MI-CBT o el cuidado estándar (SC) para aumentar la adherencia a medicamento a largo plazo. Llevamos a cabo un periodo de prueba controlado de tres ramas aleatorias por 48 semanas, el cual incluye un seguimiento electrónico continuo de adherencia a medicamento. Un total de 204 participantes VIH-positivo fueron aleatoriamente asignados a 10 sesiones de terapia MI-CBT con mDOT por 24 semanas, 10 sesiones de terapia MI-CBT sola, o SC. Modelos de regresión Poisson de efectos mixtos revelaron efectos significativos de interacción de la intervención por tiempo en no-adherencia definida por el porciento de dosis no-tomadas (IRR = 1.011, CI = 1.000–1.018) y el porciento de dosis no-tomadas a tiempo (IRR = 1.006, CI = 1.001–1.011) a 30 días antes de cada evaluación. No hubo diferencias significantes entre grupos, pero el grupo de MI-CBT/mDOT tubo tendencia a tener mejor adherencia a tomar el medicamento a tiempo a las 12 semanas y peor adherencia a las 48 semanas comparado con el grupo SC. Estos resultados de efectos nulo-a-modesto en la adherencia a pesar de intervenciones intensivas, recalcan la necesidad de tener más intervenciones efectivas que ayuden a mantener una alta adherencia a largo plazo.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Changes in racial-ethnic disparities in use and adequacy of mental health care in the United States, 1990–2003.

          This study examined changes in white-black and white-Latino disparities in the use of any mental health care and minimally adequate mental health care. Using data from the 1990–1992 National Comorbidity Survey (NCS) and the 2001–2003 National Comorbidity Survey Replication (NCS-R), this study examined changes by race-ethnicity in use of mental health care among individuals age 18 to 54 with a 12-month mood or anxiety disorder. The sample consisted of 1,198 NCS respondents and 929 NCS-R respondents. Changes in disparities were estimated in the use of any mental health care in the general medical sector, the specialty mental health sector, and in total. Changes in disparities were also estimated in the use of minimally adequate mental health care (in total only). Disparities in the use of any mental health care increased over time, particularly between non-Latino whites and non-Latino blacks in the general medical sector and between non-Latino whites and Latinos in the specialty mental health sector. Disparities in the use of minimally adequate mental health care persisted between whites and blacks over time but were not detected between whites and Latinos in either period. The findings of greater racial-ethnic disparities in the general medical and specialty mental health sectors indicate that more targeted policies and programs are needed to increase use of mental health care in these health sectors among persons from racial-ethnic minority groups. The persistence of white-black disparities in the use of minimally adequate mental health care warrants further examination.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Adherence to highly active antiretroviral therapy (HAART): a meta-analysis.

            This meta-analysis synthesizes eighty-four observational studies, conducted across twenty countries, to determine the mean proportion of people who reported ≥90% adherence to prescribed highly active antiretroviral therapy (HAART) and to identify the factors associated with high levels of adherence. Eight electronic databases were searched to locate all relevant studies available by January 2010, which were then coded for sample characteristics and adherence levels. The average rate of reporting ≥90% adherent HAART adherence is 62%. However, this proportion varies greatly across studies. In particular, a greater proportion of individuals maintaining ≥90% adherence to HAART is more likely in studies with higher proportions of men who have sex with men (MSM) and lower proportions of injection drug users (IDU), with participants in an earlier stage of infection, and in studies conducted in countries characterized by lower Human Development Index (HDI) scores.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The survival benefits of AIDS treatment in the United States.

              As widespread adoption of potent combination antiretroviral therapy (ART) reaches its tenth year, our objective was to quantify the cumulative survival benefits of acquired immunodeficiency syndrome (AIDS) care in the United States. We defined eras corresponding to advances in standards of human immunodeficiency virus (HIV) disease care, including opportunistic infection prophylaxis, treatment with ART, and the prevention of mother-to-child transmission (pMTCT) of HIV. Per-person survival benefits for each era were determined using a mathematical simulation model. Published estimates provided the number of adult patients with new diagnoses of AIDS who were receiving care in the United States from 1989 to 2003. Compared with survival associated with untreated HIV disease, per-person survival increased 0.26 years with Pneumocystis jiroveci pneumonia prophylaxis alone. Four eras of increasingly effective ART in addition to prophylaxis resulted in per-person survival increases of 7.81, 11.05, 11.57, and 13.33 years, compared with the absence of treatment. Treatment for patients with AIDS in care in the United States since 1989 yielded a total survival benefit of 2.8 million years. pMTCT averted nearly 2900 infant infections, equivalent to 137,000 additional years of survival benefit. At least 3.0 million years of life have been saved in the United States as a direct result of care of patients with AIDS, highlighting the significant advances made in HIV disease treatment.
                Bookmark

                Author and article information

                Contributors
                +816-235-1059 , +816-235-1062 , goggink@umkc.edu
                Journal
                AIDS Behav
                AIDS Behav
                AIDS and Behavior
                Springer US (Boston )
                1090-7165
                1573-3254
                9 April 2013
                9 April 2013
                July 2013
                : 17
                : 6
                : 1992-2001
                Affiliations
                [ ]HIV Research Group, Department of Psychology, University of Missouri—Kansas City, 5030 Cherry Street, Ste 310, Kansas City, MO 64110 USA
                [ ]Department of Biomedical and Health Informatics, School of Medicine, University of Missouri—Kansas City, Kansas City, MO USA
                [ ]School of Medicine, University of Missouri—Kansas City, Kansas City, MO USA
                [ ]Smoking and Motivation Research Lab, Department of Psychology, University of Missouri—Kansas City, Kansas City, MO USA
                [ ]Community Health Research Group, Department of Psychology, University of Missouri—Kansas City, Kansas City, MO USA
                [ ]RAND Corporation, Santa Monica, CA USA
                [ ]Section of Infectious Diseases, Department of Medicine, University of Missouri—Kansas City, Kansas City, MO USA
                [ ]Kansas City CARE Clinic, Kansas City, MO USA
                [ ]Division of Infectious Diseases, Kansas City Veterans Affairs Medical Center, Kansas City, MO USA
                [ ]Division of Infectious Diseases, University of Kansas Medical Center, Kansas City, KS USA
                Article
                467
                10.1007/s10461-013-0467-3
                3672512
                23568228
                02ee1c9e-b99e-4f85-b68c-3ab24ff5c245
                © The Author(s) 2013

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

                History
                Categories
                Original Paper
                Custom metadata
                © Springer Science+Business Media New York 2013

                Infectious disease & Microbiology
                adherence,hiv/aids,art,motivational interviewing,directly observed therapy

                Comments

                Comment on this article